DOCIVYX
NDC 83831-103, docetaxel, injection, solution, from Avyxa Pharma, LLC.
- Product NDC
- 83831-103
- Status
- Listed
- Labeler
- Avyxa Pharma, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA215813
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83831-103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOCETAXEL160 mg/16mL
Pharmacologic classes
Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83831-103-16 | 83831010316 | 1 VIAL, GLASS in 1 CARTON (83831-103-16) / 16 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4763744e-360e-4d37-be05-cce4114548cdMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=83831-103
Use it
Look up 83831-103 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83831-103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83831-103. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.